WallStreetZenWallStreetZen

NASDAQ: QLGN
Qualigen Therapeutics Inc Earnings & Revenue

QLGN past revenue growth

How has QLGN's revenue growth performed historically?
Company
27.25%
Industry
169.3%
Market
17.86%
QLGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
QLGN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
QLGN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

QLGN earnings and revenue history

Current Revenue
$4.6M
Current Earnings
-$17.3M
Current Profit Margin
-375%

QLGN Return on Equity

Current Company
-554.9%
Current Industry
15.4%
Current Market
-8.4%
QLGN's Return on Equity (-554.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when QLGN announces earnings.

QLGN Return on Assets

Current Company
-132.2%
Current Industry
2.2%
QLGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

QLGN Return on Capital Employed

Current Company
1,005.57%
Current Industry
17.7%
QLGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

QLGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
QLGN$4.62M-$16.39M-$17.34M+14.27%N/A
SLRX$0.00-$12.53M-$12.54M-100.00%N/A
INM$5.49M-$5.75M-$6.35M+354.96%N/A
APVO$0.00-$16.84M-$17.41M-100.00%N/A
SCNI$0.00N/A-$10.95MN/AN/A

QLGN earnings dates

Next earnings date
May 14, 2024

Qualigen Therapeutics Earnings & Revenue FAQ

What were QLGN's earnings last quarter?

On Invalid Date, Qualigen Therapeutics (NASDAQ: QLGN) reported Q3 2023 earnings per share (EPS) of -$0.72, up 25.77% year over year. Total Qualigen Therapeutics earnings for the quarter were -$3.66 million. In the same quarter last year, Qualigen Therapeutics's earnings per share (EPS) was -$0.97.

If you're new to stock investing, here's how to buy Qualigen Therapeutics stock.

What was QLGN's earnings growth in the past year?

As of Q1 2024, Qualigen Therapeutics's earnings has grown year over year. Qualigen Therapeutics's earnings in the past year totalled -$17.34 million.

What is QLGN's earnings date?

Qualigen Therapeutics's earnings date is Invalid Date. Add QLGN to your watchlist to be reminded of QLGN's next earnings announcement.

What was QLGN's revenue last quarter?

On Invalid Date, Qualigen Therapeutics (NASDAQ: QLGN) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Qualigen Therapeutics's revenue was $0.00.

What was QLGN's revenue growth in the past year?

As of Q1 2024, Qualigen Therapeutics's revenue has grown 27.25% year over year. This is 142.04 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Qualigen Therapeutics's revenue in the past year totalled $4.62 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.